Caleres (CAL)
(Delayed Data from NYSE)
$37.25 USD
+0.20 (0.54%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $37.27 +0.02 (0.05%) 7:46 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$37.25 USD
+0.20 (0.54%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $37.27 +0.02 (0.05%) 7:46 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Why Caleres (CAL) Might Surprise This Earnings Season
by Zacks Equity Research
Caleres (CAL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Caleres Be a Top Choice for Value Investors?
by Zacks Equity Research
Value investing is easily one of the most popular ways to find great stocks in any market environment.
Caleres (CAL) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Caleres, Inc. (CAL) has been struggling lately, but the selling pressure may be coming to an end soon.
Why Caleres (CAL) Stock Might be a Great Pick
by Zacks Equity Research
Caleres (CAL) looks like an interesting choice for investors, as it is seeing solid estimate revisions and belongs to a great industry.
Duluth Holdings (DLTH) Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Duluth Holdings Inc. (DLTH) is scheduled to report third-quarter 2016 results on Dec 8, after the closing bell.
Anatomy of Success: Short-Term (BWS)
by Kevin Matras
See how to apply the Zacks Rank to find stocks that will outperform over the next 1-3 months.
Anatomy of Success: Brown Shoe (BWS)
by Kevin Matras
See how to apply the Zacks Rank to find stocks that will outperform over the next 1-3 months.
Brown Shoe (BWS)
by Kevin Matras
See how to apply the Zacks Rank to find stocks that will outperform over the next 1-3 months.